{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T01:40:03Z","timestamp":1770342003418,"version":"3.49.0"},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:p>Earlier, we have shown the efficacy of racemic (\u00b1) CIQ, a positive allosteric modulator of GluN2C\/2D receptor against MK-801 induced impairment of prepulse inhibition as well as working memory. The present study investigated the antipsychotic-like profile of different CIQ (\u00b1, +, \u2212) isomers against schizophrenia-like symptoms in series of behavioural animal models like apomorphine climbing, social isolation behaviour and NMDA receptor antagonist MK-801 induced cognitive deficits. Further, we also tested CIQ (\u00b1, +, \u2212) isomers in neurodevelopmental model against MK-801induced deficits using open field test, Y-maze test and novel object recognition test. CIQ (\u00b1, +, \u2212) isomers decreased climbing behaviour, increased social interaction and improved the MK-801 induced deficits in working memory in Y-maze. Further, CIQ (\u00b1, +) but not CIQ (\u2212) improved the recognition memory in novel object recognition test as well as reduced hyperlocomotion and stereotyped behaviour. We conclude that CIQ (\u00b1, +) but not CIQ (\u2212) exhibit the significant antipsychotic-like profile.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000532","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T18:27:04Z","timestamp":1576866424000},"page":"524-534","source":"Crossref","is-referenced-by-count":7,"title":["Antipsychotic-like profile of CIQ isomers in animal models of schizophrenia"],"prefix":"10.1097","volume":"31","author":[{"given":"Pushparaj","family":"Gawai","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Upadhyay","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukanya G.","family":"Gakare","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lopmudra","family":"Sarode","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashank M.","family":"Dravid","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Creighton University, Omaha, Nebraska, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh R.","family":"Ugale","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,12,18]]},"reference":[{"key":"R1-20230910","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/schbul\/sbr133","article-title":"Is the acute NMDA receptor hypofunction a valid model of schizophrenia?","volume":"38","author":"Adell","year":"2012","journal-title":"Schizophr Bull"},{"key":"R2-20230910","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1523\/JNEUROSCI.16-01-00019.1996","article-title":"Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics.","volume":"16","author":"Akbarian","year":"1996","journal-title":"J Neurosci"},{"key":"R3-20230910","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbr.2012.04.041","article-title":"The effect of neonatal N-methyl-D-aspartate receptor blockade on exploratory and anxiety-like behaviors in adult BALB\/c and C57BL\/6 mice.","volume":"233","author":"Akillioglu","year":"2012","journal-title":"Behav Brain Res"},{"key":"R4-20230910","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/bs.apha.2016.01.006","article-title":"The NMDA receptor and schizophrenia: from pathophysiology to treatment.","volume":"76","author":"Balu","year":"2016","journal-title":"Adv Pharmacol"},{"key":"R5-20230910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-012-2794-x","article-title":"The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction.","volume":"224","author":"Burkett","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"R6-20230910","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/schbul\/16.3.425","article-title":"Schizophrenia: a subcortical neurotransmitter imbalance syndrome?","volume":"16","author":"Carlsson","year":"1990","journal-title":"Schizophr Bull"},{"key":"R7-20230910","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1016\/j.bmcl.2013.07.019","article-title":"Modulation of NMDA receptor function as a treatment for schizophrenia.","volume":"23","author":"Cioffi","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"R8-20230910","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0014-2999(78)90251-0","article-title":"Climbing behaviour induced by apomorphine in mice: a potential model for the detection of neuroleptic activity.","volume":"50","author":"Costall","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"R9-20230910","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1523\/JNEUROSCI.5390-09.2010","article-title":"Structural determinants of D-cycloserine efficacy at the NR1\/NR2C NMDA receptors.","volume":"30","author":"Dravid","year":"2010","journal-title":"J Neurosci"},{"key":"R10-20230910","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.brainresrev.2006.09.001","article-title":"Early brain development disruption from NMDA receptor hypofunction: relevance to schizophrenia.","volume":"53","author":"du Bois","year":"2007","journal-title":"Brain Res Rev"},{"key":"R11-20230910","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.biopsych.2015.01.020","article-title":"Delta frequency optogenetic stimulation of the thalamic nucleus reuniens is sufficient to produce working memory deficits: relevance to schizophrenia.","volume":"77","author":"Duan","year":"2015","journal-title":"Biol Psychiatry"},{"key":"R12-20230910","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0165-0173(94)00014-G","article-title":"The N-methyl-D aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anat omical models of the dementias.","volume":"20","author":"Ellison","year":"1995","journal-title":"Brain Res Rev"},{"key":"R13-20230910","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/schbul\/sbn187","article-title":"The neurodevelopmental hypothesis of schizophrenia, revisited.","volume":"35","author":"Fatemi","year":"2009","journal-title":"Schizophr Bull"},{"key":"R14-20230910","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/FBP.0000000000000003","article-title":"MK-801-induced and scopolamine-induced hyperactivity in rats neonatally treated chronically with MK-801.","volume":"24","author":"Furuie","year":"2013","journal-title":"Behav Pharmacol"},{"key":"R15-20230910","first-page":"690","article-title":"Animal models relevant to schizophrenia disorders.","volume":"50","author":"Geyer","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"R16-20230910","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/schbul\/sbs012","article-title":"D-cycloserine: an evolving role in learning and neuroplasticity in schizophrenia.","volume":"38","author":"Goff","year":"2012","journal-title":"Schizophr Bull"},{"key":"R17-20230910","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fnsys.2015.00029","article-title":"Role of the thalamic nucleus reuniens in mediating interactions between the hippocampus and medial prefrontal cortex during spatial working memory.","volume":"9","author":"Griffin","year":"2015","journal-title":"Front Syst Neurosci"},{"key":"R18-20230910","doi-asserted-by":"crossref","first-page":"783297","DOI":"10.1155\/2010\/783297","article-title":"Postnatal BDNF expression profiles in prefrontal cortex and hippocampus of a rat schizophrenia model induced by MK-801 administration.","volume":"2010","author":"Guo","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"R19-20230910","doi-asserted-by":"crossref","first-page":"e13722","DOI":"10.1371\/journal.pone.0013722","article-title":"Essential role of NMDA receptor channel \u03b54 subunit (glun2d) in the effects of phencyclidine, but not methamphetamine.","volume":"5","author":"Hagino","year":"2010","journal-title":"Plos One"},{"key":"R20-20230910","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1046\/j.1460-9568.2003.02902.x","article-title":"Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism.","volume":"18","author":"Harris","year":"2003","journal-title":"Eur J Neurosci"},{"key":"R21-20230910","first-page":"1","article-title":"Studies of GluN2C-containing NMDA receptors in schizophrenia-like behaviors and fear learning: relevance to the glutamate hypofunction hypothesis of schizophrenia.","author":"Hillman","year":"2012","journal-title":"ProQuest Diss Publ"},{"key":"R22-20230910","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nlm.2011.01.008","article-title":"Behavioral analysis of NR2C knockout mouse reveals deficit in acquisition of conditioned fear and working memory.","volume":"95","author":"Hillman","year":"2011","journal-title":"Neurobiol Learn Mem"},{"key":"R23-20230910","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature14396","article-title":"A prefrontal-thalamo-hippocampal circuit for goal-directed spatial navigation.","volume":"522","author":"Ito","year":"2015","journal-title":"Nature"},{"key":"R24-20230910","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia.","volume":"148","author":"Javitt","year":"1991","journal-title":"Am J Psychiatry"},{"key":"R25-20230910","doi-asserted-by":"crossref","first-page":"11151","DOI":"10.1523\/JNEUROSCI.1203-16.2016","article-title":"The role of glun2c-containing NMDA receptors in ketamine\u2019s psychotogenic action and in schizophrenia models.","volume":"36","author":"Khlestova","year":"2016","journal-title":"J Neurosci"},{"key":"R26-20230910","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/0024-3205(96)00109-9","article-title":"Inhibition by noncompetitive NMDA receptor antagonists of apomorphine-induced climbing behavior in mice.","volume":"58","author":"Kim","year":"1996","journal-title":"Life Sci"},{"key":"R27-20230910","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/schbul\/19.2.355","article-title":"Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal.","volume":"19","author":"Kirch","year":"1993","journal-title":"Schizophr Bull"},{"key":"R28-20230910","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s11064-013-1008-1","article-title":"The effects of N-methyl-D-aspartate receptor blockade during the early neurodevelopmental period on emotional behaviors and cognitive functions of adolescent Wistar rats.","volume":"38","author":"Kocahan","year":"2013","journal-title":"Neurochem Res"},{"key":"R29-20230910","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbr.2009.03.028","article-title":"Behavioral abnormality and pharmacologic response in social isolation-reared mice.","volume":"202","author":"Koike","year":"2009","journal-title":"Behav Brain Res"},{"key":"R30-20230910","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"R31-20230910","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1196\/annals.1300.063","article-title":"Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment.","volume":"1003","author":"Laruelle","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"R32-20230910","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tins.2008.02.005","article-title":"Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.","volume":"31","author":"Lisman","year":"2008","journal-title":"Trends Neurosci"},{"key":"R33-20230910","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biopsych.2010.04.007","article-title":"A thalamo-hippocampal-ventral tegmental area loop may produce the positive feedback that underlies the psychotic break in schizophrenia.","volume":"68","author":"Lisman","year":"2010","journal-title":"Biol Psychiatry"},{"key":"R34-20230910","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/07853890310010005","article-title":"The neurodevelopmental hypothesis of schizophrenia: a review of recent developments.","volume":"35","author":"McGrath","year":"2003","journal-title":"Ann Med"},{"key":"R35-20230910","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1096\/fj.06-7685com","article-title":"Oral vaccination with a viral vector containing abeta cdna attenuates age-related abeta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model.","volume":"21","author":"Mouri","year":"2007","journal-title":"Faseb J"},{"key":"R36-20230910","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/ncomms1085","article-title":"A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors.","volume":"1","author":"Mullasseril","year":"2010","journal-title":"Nat Commun"},{"key":"R37-20230910","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1007\/s00213-014-3580-8","article-title":"Enriched environment prevents cognitive and motor deficits associated with postnatal MK-801 treatment.","volume":"231","author":"Nozari","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"R39-20230910","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0079-6123(08)60543-9","article-title":"Synaptic development of the cerebral cortex: implications for learning, memory, and mental illness.","volume":"102","author":"Rakic","year":"1994","journal-title":"Prog Brain Res"},{"key":"R40-20230910","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/sj.mp.4001642","article-title":"The neurodevelopmental model of schizophrenia: update 2005.","volume":"10","author":"Rapoport","year":"2005","journal-title":"Mol Psychiatry"},{"key":"R41-20230910","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/mp.2012.23","article-title":"Neurodevelopmental model of schizophrenia: update 2012.","volume":"17","author":"Rapoport","year":"2012","journal-title":"Mol Psychiatry"},{"key":"R42-20230910","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1021\/jm500710w","article-title":"Correction to synthesis and structure activity relationship of tetrahydroisoquinoline-based potentiators of glun2c and glun2d containing N-methyl-d-aspartate receptors.","volume":"57","author":"Santangelo Freel","year":"2014","journal-title":"J Med Chem"},{"key":"R43-20230910","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1021\/jm400177t","article-title":"Synthesis and structure activity relationship of tetrahydroisoquinoline-based potentiators of glun2c and glun2d containing N-methyl-D-aspartate receptors.","volume":"56","author":"Santangelo Freel","year":"2013","journal-title":"J Med Chem"},{"key":"R44-20230910","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.neurobiolaging.2014.06.020","article-title":"Synergistic associations of catechol-O-methyltransferase and brain-derived neurotrophic factor with executive function in aging are selective and modified by apolipoprotein E.","volume":"36","author":"Sapkota","year":"2015","journal-title":"Neurobiol Aging"},{"key":"R45-20230910","first-page":"405","article-title":"[Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].","volume":"27","author":"Semkovska","year":"2001","journal-title":"Encephale"},{"key":"R46-20230910","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jneumeth.2007.06.032","article-title":"Automation of the novel object recognition task for use in adolescent rats.","volume":"166","author":"Silvers","year":"2007","journal-title":"J Neurosci Methods"},{"key":"R47-20230910","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/syn.890190405","article-title":"Glutamate\/dopamine D1\/D2 balance in the basal ganglia and its relevance to Parkinson's disease.","volume":"19","author":"Starr","year":"1995","journal-title":"Synapse"},{"key":"R48-20230910","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.biopsych.2004.11.031","article-title":"Transient N-methyl-D-aspartate receptor blockade in early development causes lasting cognitive deficits relevant to schizophrenia.","volume":"57","author":"Stefani","year":"2005","journal-title":"Biol Psychiatry"},{"key":"R49-20230910","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/WNR.0b013e328346e154","article-title":"Age-specific effects of early MK-801 treatment on working memory in female rats.","volume":"22","author":"Su","year":"2011","journal-title":"Neuroreport"},{"key":"R50-20230910","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/bph.12518","article-title":"Glun2c\/glun2d subunit-selective NMDA receptor potentiator CIQ reverses MK-801-induced impairment in prepulse inhibition and working memory in Y-maze test in mice.","volume":"171","author":"Suryavanshi","year":"2014","journal-title":"Br J Pharmacol"},{"key":"R51-20230910","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1460-9568.2003.02466.x","article-title":"Endogenous and exogenous dopamine presynaptically inhibits glutamatergic reticulospinal transmission via an action of D2-receptors on N-type ca2+ channels.","volume":"17","author":"Svensson","year":"2003","journal-title":"Eur J Neurosci"},{"key":"R52-20230910","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuropharm.2009.06.035","article-title":"Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine.","volume":"57","author":"Taksande","year":"2009","journal-title":"Neuropharmacology"},{"key":"R53-20230910","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.neuroscience.2005.08.070","article-title":"Dopaminergic control of working memory and its relevance to schizophrenia: a circuit dynamics perspective.","volume":"139","author":"Tanaka","year":"2006","journal-title":"Neuroscience"},{"key":"R54-20230910","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.brainres.2010.07.013","article-title":"Neonatal exposure to MK-801, an N-methyl-D-aspartate receptor antagonist, enhances methamphetamine-induced locomotion and disrupts sensorimotor gating in pre- and postpubertal rats.","volume":"1352","author":"Uehara","year":"2010","journal-title":"Brain Res"},{"key":"R55-20230910","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/sj.npp.1300460","article-title":"Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents.","volume":"29","author":"Ugale","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"R56-20230910","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/mp.2012.137","article-title":"Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia.","volume":"18","author":"Weickert","year":"2013","journal-title":"Mol Psychiatry"},{"key":"R57-20230910","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3371\/CSRP.4.2.4","article-title":"Neurodevelopmental animal models of schizophrenia: role in novel drug discovery and development.","volume":"4","author":"Wilson","year":"2010","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"R58-20230910","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0006-8993(00)02135-1","article-title":"Striatal interneurons expressing calretinin, parvalbumin or NADPH-diaphorase: a comparative study in the rat, monkey and human.","volume":"863","author":"Wu","year":"2000","journal-title":"Brain Res"},{"key":"R59-20230910","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/1566524015666150330142807","article-title":"Specific roles of NMDA receptor subunits in mental disorders.","volume":"15","author":"Yamamoto","year":"2015","journal-title":"Curr Mol Med"},{"key":"R60-20230910","doi-asserted-by":"crossref","first-page":"11534","DOI":"10.1523\/JNEUROSCI.1811-14.2014","article-title":"Opposing role of NMDA receptor glun2b and glun2d in somatosensory development and maturation.","volume":"34","author":"Yamasaki","year":"2014","journal-title":"J Neurosci"},{"key":"R61-20230910","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1111\/bph.12758","article-title":"Allosteric modulation of glun2c\/glun2d-containing NMDA receptors bidirectionally modulates dopamine release: implication for Parkinson's disease.","volume":"171","author":"Zhang","year":"2014","journal-title":"Br J Pharmacol"},{"key":"R62-20230910","first-page":"20","article-title":"Inhibition of nmdars in the nucleus reticularis of the thalamus produces delta frequency bursting.","volume":"3","author":"Zhang","year":"2009","journal-title":"Front Neural Circuits"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T08:12:42Z","timestamp":1694333562000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,18]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000532","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,18]]}}}